Search Results

240 results for CTX

7 Stock Bargains Worth a Look After the Most Recent Pullback

By Chris Lau, InvestorPlace Contributor

Value investors may choose to buy stocks that are out of favor and from among beaten up stock bargains in a variety of sectors.

Is CRISPR Therapeutics Worth It Without Drugs?

By Dana Blankenhorn, InvestorPlace Contributor

We’re still very early in the development of gene editing, and CRISPR Therapeutics is one of the first out of the block. But it’s not…

7 Potential Biotech Stocks Buyout Targets in 2022

By Shanthi Rexaline

Big biopharma companies usually rely on M&A to get immediate access to a new class of drug or technology, fill in the gap in their…

3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time

By John Blankenhorn, InvestorPlace Contributor

For investors betting on healthcare, look for these three companies to provide the treatments of tomorrow.

3 Top Gene Therapy Stocks That Could Soar

By Aaron Levitt, InvestorPlace Contributor

Biotech stocks targeting gene therapy are going to be huge. Here are 3 gene therapy stocks to buy that have a ton of potential.

Investing in CRISPR Stocks: Ultimate Genetic Editing Guide

By Luke Lango, InvestorPlace Senior Investment Analyst

The biotech space is on the verge of hypergrowth, thanks to a scientific breakthrough in genetic editing. This is your ultimate guide to understanding and…

3 Cash-Rich Biotech Stocks to Bet on for the Long Haul

By John Blankenhorn, InvestorPlace Contributor

Cash rich biotech stocks can survive while most of their peers struggle with rising interest rates. Here are three to watch.

7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition

By Omor Ibne Ehsan

With a modest $1,000 investment, these stocks offer the potential for market-beating gains through solid fundamentals and growth prospects.

3 Biotech Stocks With the Strongest Clinical Pipelines

By Ian Cooper, InvestorPlace Contributor

Many industry heavyweights are on the hunt for fresh new ideas — great news for biotech stocks to buy with strong pipelines.

ENTX Stock: 11 Things for Entera Bio Investors to Know as Shares Blast 200%+ Higher

By William White, InvestorPlace Writer

Entera Bio (ENTX) stock is soaring higher on Thursday following an update from the biotech company about its osteoporosis treatment.

3 Biotech Stocks With the Potential to Make You an Overnight Millionaire

By Joel Lim, InvestorPlace Contributor

Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.

Back Out of the Banks

By Sam Collins, InvestorPlace Chief Technical Analyst

If you’ve ridden the financial sector’s recovery to the current level, it’s time to take profits or lighten up.

Crispr Therapeutics Represents the Best of Emerging Biotechnology

By Alex Sirois, InvestorPlace Contributor

CRSP stock may end up being a pioneer, or it may fizzle. The timeline until we know is typical of biotech stocks.

Four Housing Stocks Ready to Burst

By Jamie Dlugosch, InvestorPlace Writer

Has the housing market finally bottomed out? The fact is by the time we can definitively declare a bottom, prices will have already exploded higher.…

5 Growthy Biotech Stocks to Buy Despite the Scrutiny

By Chris Lau, InvestorPlace Contributor

Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?

Solana vs. Ethereum: Why This Billionaire Thinks SOL Crypto Is the One to Bet On

By Samuel O'Brient, InvestorPlace Reporter

Experts think that Solana is a better investment than Ethereum. What does this mean for the long- and short-term future of the SOL crypto?

3 DNA Stocks That Are on the Uptrend

By InvestorPlace Research Staff

The future of genetic medicine is bright, but bumpy. But these bumps will provide many opportunities to buy DNA stocks along the way.

3 Gene Therapy Stocks to Play Biotech’s Future

By InvestorPlace Research Staff

No matter what risks you think lay ahead for the market (trade war, rate hikes, government shutdown), none of them hurt gene therapy stocks

Vertex Pharmaceuticals Is a Biotech Play With No Coronavirus Exposure

By Louis Navellier and the InvestorPlace Research Staff

VRTX stock is a biopharmaceutical with an A-Rating that has no stake in the risky race for a coronavirus treatment.

One Step Closer to a Medical Game Changer

By InvestorPlace Research Staff

We don’t get many chances to invest in a once-in-a-lifetime, game-changing medical breakthrough. We need to take full advantage.

3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later

By Chris Markoch, InvestorPlace Contributor

Even in a risk-off market, gene editing stocks look attractive. Here are three stocks that may be worth a closer look at this time.

Can CRISPR Therapeutics Stock Investors Steer Clear of Ethical Concerns?

By Josh Enomoto, InvestorPlace Contributor

While the technologies that undergird CRSP stock is nothing short of mind-blowing, you should be aware of the ethical risks.

Peloton Isn’t the ONLY Takeover Target. What Companies Could Be Bought Out in 2022?

By Tezcan Gecgil, InvestorPlace Contributor

Savvy investors can generate lucrative returns by investing in companies that look like prime takeover targets. This article speculates on a number of takeover targets…

3 Biotech Stocks That Are Set for a Breakthrough

By InvestorPlace Research Staff

If you’re looking for biotech stocks to buy with massive breakthrough potential in gene editing, then these three are kings among the rest.

2 – 10 of 240 results